B-cell Lymphoma

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

B-cell Lymphoma Trial in Beijing (Relmacabtagene Autoleucel, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • B-cell Lymphoma
  • Relmacabtagene Autoleucel
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Oct 19, 2022

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

B-cell Lymphoma Trial in Beijing, Guangzhou (LP-168 tablet)

Recruiting
  • B-cell Lymphoma
  • LP-168 tablet
  • Beijing, Beijing, China
  • +2 more
Feb 24, 2022

B-cell Lymphoma Trial in China (Zanubrutinib)

Completed
  • B-cell Lymphoma
  • Beijing, Beijing, China
  • +3 more
Sep 26, 2021

B-Cell Lymphoma Trial in Beijing (GB241, Rituximab)

Completed
  • B-Cell Lymphoma
  • GB241
  • Rituximab
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 19, 2021

B-Cell Lymphoma Trial in China (IBI301, Rituximab)

Completed
  • B-Cell Lymphoma
  • Beijing, Beijing, China
  • +11 more
Aug 30, 2020

B-cell Lymphoma Trial in Beijing, Hangzhou (AC0010MA)

Unknown status
  • B-cell Lymphoma
  • Beijing, Beijing, China
  • +1 more
Jan 31, 2019

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in Beijing (PZ01 CAR-T cells)

Unknown status
  • B-cell Acute Lymphoblastic Leukemia
  • B-cell Lymphoma
  • PZ01 CAR-T cells
  • Beijing, Beijing, China
    Department of Hematology, Navy General Hospital of PLA
Sep 14, 2017

B-cell Lymphoma Trial in Worldwide (Bevacizumab, Rituximab, CHOP)

Terminated
  • B-cell Lymphoma
  • La Jolla, California
  • +265 more
Jun 26, 2017